From Monday 21st March the following cohorts become eligible to receive an extra Spring dose of the Covid-19 vaccine:
· adults aged 75 years and over,
· residents in a care home for older adults,
· individuals aged 12 years and over who are immunosuppressed, as defined in in the COVID 19 healthcare guidance Green Book
Green Book Definition of Immunosuppressed – Green Book – Chapter 14a, Table 3, p16
Immunosuppression due to disease or treatment, including patients undergoing chemotherapy leading to immunosuppression, patients undergoing radical radiotherapy, solid organ transplant recipients, bone marrow or stem cell transplant recipients, HIV infection at all stages, multiple myeloma or genetic disorders affecting the immune system (e.g. IRAK-4, NEMO, complement disorder, SCID).
Individuals who are receiving immunosuppressive or immunomodulating biological therapy including, but not limited to, anti-TNF, alemtuzumab, ofatumumab, rituximab, patients receiving protein kinase inhibitors or PARP inhibitors, and individuals treated with steroid sparing agents such as cyclophosphamide and mycophenolate mofetil.
Individuals treated with or likely to be treated with systemic steroids for more than a month at a dose equivalent to prednisolone at 20mg or more per day for adults.
Anyone with a history of haematological malignancy, including leukaemia, lymphoma, and myeloma.
Those who require long term immunosuppressive treatment for conditions including, but not limited to, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, scleroderma and psoriasis.
Some immunosuppressed patients may have a suboptimal immunological response to the vaccine (see Immunosuppression and HIV).
The latest JCVI guidance can be found here. It is important to note that at this stage additional boosters are only available to those listed above which does not include patients previously identified as Clinically Extremely Vulnerable as well as health and social care workers.
The GP Federation team have begun contacting eligible cohorts of patients and appointments will also be made available on the national booking system.